Medistim ASA (FRA:MD1)

Market Cap	337.66M
Revenue (ttm)	53.11M
Net Income (ttm)	10.81M
Shares Out	n/a
EPS (ttm)	0.59
PE Ratio	31.25
Forward PE	30.42
Dividend	0.51 (2.75%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	486
Open	19.45
Previous Close	19.05
Day's Range	19.45 - 19.45
52-Week Range	11.10 - 19.45
Beta	n/a
RSI	59.88
Earnings Date	Aug 20, 2025

About Intra-Cellular Therapies

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.